Finally, emerging research is exploring how GLP-1 RAs may modulate central pain pathways, an area with significant therapeutic promise.17These findings may pave the way for novel interventions targeting chronic headache and migraine, particularly in patients with treatment-resistant forms of the disease. The gene discussed is GCG; the disease is headache disorder.